SkinBioTherapeutics (LON:SBTX) Trading Up 2.9%

SkinBioTherapeutics plc (LON:SBTXGet Free Report)’s share price shot up 2.9% on Friday . The stock traded as high as GBX 9 ($0.11) and last traded at GBX 8.75 ($0.11). 235,810 shares traded hands during trading, a decline of 64% from the average session volume of 651,189 shares. The stock had previously closed at GBX 8.50 ($0.11).

SkinBioTherapeutics Stock Up 2.9 %

The stock has a market cap of £17.53 million, a PE ratio of -437.50 and a beta of 1.67. The business has a fifty day moving average of GBX 9.49 and a 200-day moving average of GBX 11.04. The company has a debt-to-equity ratio of 2.66, a current ratio of 6.57 and a quick ratio of 10.01.

SkinBioTherapeutics Company Profile

(Get Free Report)

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.

Read More

Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.